Promega Corporation

Characterizing Responses to Treatments Using Homogeneous Caspase Activity and Cell...

Characterizing Responses to Treatments Using Homogeneous Caspase Activity and Cell Viability Assays
  • Share
  • Print
  • Email
  • Download PDF
  • Article
  • Comments & Ratings

Abstract

Promega now offers a complement of fluorescent and luminescent methods to measure caspase activities and correlates of cellular health. Homogeneous caspase assays are available to measure caspase-3/7, caspase-8 and caspase-9. These caspase assays can be used in parallel with Promega cell viability assays to provide a more complete picture of how a treatment or compound affects cell viability. Furthermore, the add-mix-measure format provides a simple and efficient means to scale the assays for increased volumes or high-throughput use. 

Cell Notes 9, 11–14.

Andrew Niles, Rich Moravec, and Terry Riss

Promega Corporation
Publication Date: 2004

Download Article (153 KB)

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.

Click Here for Technical Questions and Ordering Support »